Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Viridian Therapeutics Inc., 3 years.
Viridian Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 4, 2026 | Agios Pharmaceuticals Inc. | Open-market sale | −30,000 | $30.48 | $914,400 |
| Jul 1, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +8,375 | — | — |
| Jul 1, 2026 | Agios Pharmaceuticals Inc. | Open-market sale | −4,007 | $37.56 | $150,503 |
| Apr 2, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +8,500 | — | — |
| Apr 2, 2026 | Agios Pharmaceuticals Inc. | Open-market sale | −2,940 | $34.71 | $102,047 |
| Mar 2, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +4,000 | — | — |
| Mar 2, 2026 | Agios Pharmaceuticals Inc. | Open-market sale | −1,187 | $28.96 | $34,376 |
| Mar 2, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +5,666 | — | — |
| Mar 2, 2026 | Agios Pharmaceuticals Inc. | Open-market sale | −1,681 | $28.96 | $48,682 |
| Mar 2, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +4,000 | — | — |
| Mar 2, 2026 | Agios Pharmaceuticals Inc. | Open-market sale | −1,187 | $28.96 | $34,376 |
| Dec 30, 2025 | Agios Pharmaceuticals Inc. | Option exercise | +6,000 | — | — |
| Dec 30, 2025 | Agios Pharmaceuticals Inc. | Open-market sale | −2,932 | $27.09 | $79,428 |
| Nov 11, 2025 | Agios Pharmaceuticals Inc. | Option exercise | +2,454 | $25.01 | $61,375 |
| Nov 11, 2025 | Agios Pharmaceuticals Inc. | Open-market sale | −2,454 | $43.78 | $107,436 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.